Increased bioaffinity and anti-inflammatory activity of florfenicol nanocrystals by wet grinding method / Yuqi Fang, Shuqi Li, Lijuan Ye, Jun Yi, Xiaofang Li, Chongkai Gao, Fang Wu, Bohong Guo
Abstract Context: The main objective of the current study is to improve the water solubility of florfenicol (FF) and evaluate changes in its pharmacokinetics and anti-inflammatory activity. Materials and methods: Florfenicol nanocrystals (FF-NC) were prepared by wet grinding combined with spray drying. The characterisations, pharmacokinetics, and anti-inflammatory activity of FF-NC were evaluated. Results: The particle size, polydispersity index (PDI), and zeta potential of FF-NC were 276.4 ± 19.4 nm, 0.166 ± 0.011, and –18.66 ± 5.25 mV, respectively. Compared with FF, FF-NC showed a better dissolution rate in media at different pH. Pharmacokinetic experiments showed the area under the curve (AUC 0– t ), maximum concentration ( C max ), and mean residence time (MRT) of FF-NC were about 4.62-fold, 2.86-fold, and 1.68-fold higher compared with FF, respectively. In vitro anti-inflammatory experiments showed that FF inhibited the secretion of tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and synthesis of NO in a dose-dependent manner, while FF-NC showed a stronger anti-inflammatory effect than FF under the same dose. Conclusion: FF-NC are an effective way to improve the bioaffinity and anti-inflammatory effects of FF.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Journal of microencapsulation - 37(2020), 2, Seite 109-120 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fang, Yuqi [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Themen: |
Anti-inflammatory |
---|
Umfang: |
1 Online-Ressource (12 p) |
---|
doi: |
10.1080/02652048.2019.1701115 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
KFL011203919 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL011203919 | ||
003 | DE-627 | ||
005 | 20231109210046.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230714s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/02652048.2019.1701115 |2 doi | |
035 | |a (DE-627)KFL011203919 | ||
035 | |a (KFL)prod_LgpH_10.1080/02652048.2019.1701115 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Fang, Yuqi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Increased bioaffinity and anti-inflammatory activity of florfenicol nanocrystals by wet grinding method |c Yuqi Fang, Shuqi Li, Lijuan Ye, Jun Yi, Xiaofang Li, Chongkai Gao, Fang Wu, Bohong Guo |
264 | 1 | |c 2020 | |
300 | |a 1 Online-Ressource (12 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Context: The main objective of the current study is to improve the water solubility of florfenicol (FF) and evaluate changes in its pharmacokinetics and anti-inflammatory activity. Materials and methods: Florfenicol nanocrystals (FF-NC) were prepared by wet grinding combined with spray drying. The characterisations, pharmacokinetics, and anti-inflammatory activity of FF-NC were evaluated. Results: The particle size, polydispersity index (PDI), and zeta potential of FF-NC were 276.4 ± 19.4 nm, 0.166 ± 0.011, and –18.66 ± 5.25 mV, respectively. Compared with FF, FF-NC showed a better dissolution rate in media at different pH. Pharmacokinetic experiments showed the area under the curve (AUC 0– t ), maximum concentration ( C max ), and mean residence time (MRT) of FF-NC were about 4.62-fold, 2.86-fold, and 1.68-fold higher compared with FF, respectively. In vitro anti-inflammatory experiments showed that FF inhibited the secretion of tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and synthesis of NO in a dose-dependent manner, while FF-NC showed a stronger anti-inflammatory effect than FF under the same dose. Conclusion: FF-NC are an effective way to improve the bioaffinity and anti-inflammatory effects of FF | ||
653 | |a Wet grinding | ||
653 | |a florfenicol nanocrystals | ||
653 | |a solubility | ||
653 | |a pharmacokinetics | ||
653 | |a anti-inflammatory | ||
700 | 1 | |a Li, Shuqi |e verfasserin |4 aut | |
700 | 1 | |a Ye, Lijuan |e verfasserin |4 aut | |
700 | 1 | |a Yi, Jun |e verfasserin |4 aut | |
700 | 1 | |a Li, Xiaofang |e verfasserin |4 aut | |
700 | 1 | |a Gao, Chongkai |e verfasserin |4 aut | |
700 | 1 | |a Wu, Fang |e verfasserin |4 aut | |
700 | 1 | |a Guo, Bohong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of microencapsulation |d Abingdon : Taylor & Francis Group, 1984 |g 37(2020), 2, Seite 109-120 |h Online-Ressource |w (DE-627)KFL000005967 |w (DE-600)1491079-2 |w (DE-576)079719244 |x 1464-5246 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2020 |g number:2 |g pages:109-120 |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.1080/02652048.2019.1701115 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
912 | |a ZDB-1-TFE | ||
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
935 | |i IMPORT_0628_prod_LgpH_02 | ||
951 | |a AR | ||
952 | |d 37 |j 2020 |e 2 |h 109-120 |